People with elevated Lp(a) levels and previous atherosclerotic cardiovascular disease (ASCVD) use more healthcare resources, with greater costs and higher rates of major adverse cardiovascular events (MACE) than those with ASCVD alone, according to healthcare data from Alberta, Canada.
